Defining a new diagnostic biomarker panel for malignant pleural mesothelioma using a novel proteomic technique
E. Schillebeeckx (Wilrijk, Belgium), E. Fernandez (Ghent, Belgium), M. Vuylsteke (Ghent, Belgium), D. Fijalkowska (Ghent, Belgium), A. Staes (Ghent, Belgium), J. Van Meerbeeck (Edegem, Belgium), K. Gevaert (Ghent, Belgium), K. Lamote (Wilrijk, Belgium)
Source: International Congress 2022 – Malignant pleural effusion and mesothelioma: diagnosis and optimal management
   
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Schillebeeckx (Wilrijk, Belgium), E. Fernandez (Ghent, Belgium), M. Vuylsteke (Ghent, Belgium), D. Fijalkowska (Ghent, Belgium), A. Staes (Ghent, Belgium), J. Van Meerbeeck (Edegem, Belgium), K. Gevaert (Ghent, Belgium), K. Lamote (Wilrijk, Belgium). Defining a new diagnostic biomarker panel for malignant pleural mesothelioma using a novel proteomic technique. 786
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|